Back
Knight Therapeutics Stock Price Chart
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
16
GUD.TO
Knight Therapeutics
Last Price:
5.28
Seasonality Move:
0.47%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GUD.TO is experiencing slight selling pressure.
Knight Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.34 | Sell |
| 20-day SMA: | 5.29 | Sell |
| 50-day SMA: | 5.48 | Sell |
| 200-day SMA: | 5.65 | Sell |
| 8-day EMA: | 5.32 | Sell |
| 20-day EMA: | 5.33 | Sell |
| 50-day EMA: | 5.45 | Sell |
| 200-day EMA: | 5.54 | Sell |
Knight Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 44.63 | Sell |
| Chaikin Money Flow: | -9807 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.18 - 5.34) | Buy |
| Bollinger Bands (100): | (5.36 - 5.88) | Sell |
Knight Therapeutics Technical Analysis
| Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Knight Therapeutics Stock
Is Knight Therapeutics Stock a Buy?
- Knight Therapeutics share price is 5.28 while GUD.TO 8-day simple moving average is 5.34, which is a Sell signal.
- The stock price of GUD.TO is 5.28 while Knight Therapeutics 20-day SMA is 5.29, which makes it a Sell.
- Knight Therapeutics 50-day simple moving average is 5.48 while GUD.TO share price is 5.28, making it a Sell technically.
- GUD.TO stock price is 5.28 and Knight Therapeutics 200-day simple moving average is 5.65, creating a Sell signal.
GUD.TO Technical Analysis vs Fundamental Analysis
Sell
16
Knight Therapeutics (GUD.TO)
is a Sell
Is Knight Therapeutics a Buy or a Sell?
-
Knight Therapeutics stock is rated a Sell
The current Knight Therapeutics [GUD.TO] share price is $5.28. The Score for GUD.TO is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Knight Therapeutics Stock Info
Market Cap:
532.24M
Price in USD:
5.28
Share Volume:
68.65K
Knight Therapeutics 52-Week Range
52-Week High:
6.23
52-Week Low:
5.07
Sell
16
Knight Therapeutics (GUD.TO)
is a Sell
Knight Therapeutics Share Price Forecast
-
What is the Knight Therapeutics stock price today?
The Knight Therapeutics stock price is 5.28 USD today. -
Will GUD.TO stock go up or go down?
Knight Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Knight Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Knight Therapeutics is overvalued.
Is Knight Therapeutics Stock a Buy?
- Knight Therapeutics share price is 5.28 while GUD.TO 8-day exponential moving average is 5.32, which is a Sell signal.
- The stock price of GUD.TO is 5.28 while Knight Therapeutics 20-day EMA is 5.33, which makes it a Sell.
- Knight Therapeutics 50-day exponential moving average is 5.45 while GUD.TO share price is 5.28, making it a Sell technically.
- GUD.TO stock price is 5.28 and Knight Therapeutics 200-day simple moving average is 5.54, creating a Sell signal.
Fundamental Analysis of Knight Therapeutics
Is Knight Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and an increase next year of $0.10 per share.
Technical Analysis of Knight Therapeutics
Should I short Knight Therapeutics stock?
- GUD.TO Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Knight Therapeutics is a Sell
- Knight Therapeutics Relative Strength Index (RSI) is 44.63, which suggest Knight Therapeutics is oversold
- The Bollinger Bands (25) for Knight Therapeutics is (5.18 - 5.34), which suggest Knight Therapeutics is a Sell
- The Bollinger Bands (100) for Knight Therapeutics is (5.36 - 5.88), which suggest Knight Therapeutics is a Sell
* Knight Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.